NVNO
enVVeno Medical Corp
+0.39 (+4.31%)9.44USD3.5K成交股數6.4M市值–本益比(近四季)40.0股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.1M | 2.1M | 1.9M | 2.6M | 2.9M | 2.6M | 2.9M | 2.8M | 3.1M | 3.0M | 2.8M | 4.2M |
| 銷售管理費用 | 1.7M | 2.0M | 2.1M | 2.3M | 4.2M | 2.4M | 3.3M | 2.6M | 2.5M | 3.3M | 2.6M | 2.6M |
| 營業利益 | −3.8M-46% | −4.1M-18% | −4.0M-35% | −4.9M-10% | −7.0M+28% | −5.0M-21% | −6.2M+15% | −5.5M-20% | −5.5M | −6.3M | −5.3M | −6.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.6M-46% | −3.8M-15% | −3.7M-34% | −4.5M-8% | −6.7M+34% | −4.5M-20% | −5.6M+13% | −5.0M-23% | −5.0M | −5.6M | −5.0M | −6.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -5.37-53% | -5.89-24% | -13.56+3774% | -0.23-26% | -11.52+3616% | -7.75+2400% | -0.35-22% | -0.31-47% | -0.31 | -0.31 | -0.45 | -0.58 |
| 稀釋股數 | 671K | 654K | 589K | 20.2M | 581K | 581K | 16.1M | 16.1M | 16.1M | 12.3M | 11.2M | 11.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 2.8M | 2.6M | 3.1M | 1.5M | 2.0M | 2.9M | 17.9M | 2.4M | 2.3M | 3.6M | 4.9M | 4.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 22.7M | 26.1M | 29.6M | 32.4M | 36.6M | 40.6M | 50.4M | 41.0M | 44.8M | 48.6M | 28.1M | 32.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.0M | 2.4M | 2.4M | 2.9M | 3.5M | 2.3M | 3.0M | 2.6M | 2.5M | 2.4M | 3.2M | 3.3M |
| 股東權益 | 20.7M | 23.7M | 27.1M | 29.4M | 33.1M | 38.3M | 47.4M | 38.4M | 42.4M | 46.2M | 24.9M | 28.8M |
| 負債比 | 8.8% | 9.0% | 8.2% | 9.0% | 9.6% | 5.6% | 6.0% | 6.3% | 5.5% | 5.0% | 11.3% | 10.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.2M-19% | – | – | – | −4.0M | – | – | −3.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 10K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −3.6M | – | – | – |
| 折舊攤銷 | – | 31K | – | – | – | 40K | – | – | 55K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2019 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2019 年度 · 31K
| Royalty Income | 31K | 100.0% | -73.1% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −19.5M | –% | -33.06 | −15.6M |
| FY2024 | – | – | −21.8M | –% | -44.53 | −16.9M |
| FY2023 | – | – | −23.5M | –% | -1.91 | −18.9M |
| FY2022 | 161K | +747.4% | −24.7M | -15,322.4% | -2.20 | −15.7M |
| FY2021 | 19K | +408.2% | −16.5M | -86,989.5% | -1.90 | −12.2M |
| FY2020 | 4K | -88.0% | −9.1M | -244,329.7% | -7.54 | −7.9M |
| FY2019 | 31K | -83.3% | −7.6M | -24,406.7% | -12.10 | −6.3M |
| FY2018 | 187K | – | −13.0M | -6,991.5% | -1.75 | −6.4M |